wound-congress-dermatology-congress-2018-keynote

7 / 9

Volume 4 Clinical Pediatric Dermatology
ISSN: 2472-0143
Page 34
Notes:
October 15-16, 2018 Rome, Italy
&
JOINT EVENT
14th International Conference on Clinical Dermatology
5th International Conference on
Advances in Skin, Wound Care and Tissue Science
Wound Congress 2018 &
Clinical Dermatology Congress 2018
October 15-16, 2018
NovoSorb biodegradable temporising matrix (BTM) - Use in significant burns
Introduction: The NovoSorb BTM is a completely synthetic bilayer material comprising a dermal component (2mm thick
biodegradable polyurethane foam) bonded to a pseudoepidermis of non-biodegradable polyurethane film. Its primary function
is to ‘temporise’ wounds, buying time for a definitive closure option to become available. Since the dermal foam becomes
integrated and creates a neodermis, it is an ‘active’ temporiser, improving the wound bed for definitive closure.
Methods: To date, 18 patients with significant burns have been treated with BTM. Since the first, salient lessons regarding the
application (contouring, cutting and fixing), dressing, monitoring, and timing of delamination and grafting have presented
themselves. , The initial 5 patients were part of a pilot trial, the following two (involved in the Pinery Bushfire Disaster)
and the subsequent 11 have been permitted by the Therapeutic Goods Administration (TGA) either under Special Access or
Authorised Prescriber Schemes. In all cases a photographic (and sometimes video) record has been taken at every procedure
and review and several cases will be discussed.
Results/Conclusions: The matrix integrated completely in almost all cases and graft take over integrated BTM was uniformly
excellent. Several episodes of localized infection were treated by local manoeuvres, dressings and systemic antibiotics without
removal or loss of the BTM. Some BTM required removal and replacement. The split skin grafts applied over integrated BTM
varied from sheet graft to 1:3 mesh. Graft loss was rare and in all cases, mesh pattern faded, becoming invisible in some by 12
months. Functional and cosmetic outcomes (measured by POSAS and MAPS) have been significantly better than historical
cases. Reconstruction within BTM areas has been limited to web space releases and simple flap release of unusual contracture
bands. BTM is now our treatment of choice and has led to a recent paradigm shift in burn care at our institution.
Biography
John GreenwoodAM is an English-trained plastic surgeon who graduated from the University of Manchester in 1989 and now working full-time in burn care as the Medical
Director of the Adult Burn Centre of the Royal Adelaide Hospital in Adelaide, South Australia. He has been developing skin replacement products, utilizing the NovoSorb
biodegradable polyurethane platform, since 2004. He was appointed Member of the Order of Australia (AM) following his work leading Australia’s only Burns Assessment
Team after the carnage of the 2002 Bali Bombings which killed 202 civilians. He was the 2016 South Australian of the Year.
John Edward Greenwood
Royal Adelaide Hospital, Australia
John Edward Greenwood, Clin Pediatr Dermatol 2018, Volume 4
DOI: 10.21767/2472-0143-C2-004